Solan: A sudden and massive surge in domestic sugar prices has alarmed both common households and industrial sectors across the country. Pharmaceutical and manufacturing entrepreneurs report that sugar prices have spiked by nearly Rs 20 to Rs 25 per kilogram over recent months, directly impacting operations in Asia’s prominent pharmaceutical hub, Baddi-Barotiwala-Nalagarh.
Input Costs Surge for Essential Medicines
Pharma manufacturers highlight that sugar serves as an essential raw material in several pharmaceutical and Ayurvedic formulations. In the BBN industrial belt, substantial quantities of sugar are consumed daily to manufacture syrups, chyawanprash, protein powders, natural juices, cold drinks, and allied products.
Because retail prices for these manufactured items are pre-determined, producers face extreme difficulty in passing the sudden cost inflation onto end consumers. Furthermore, regulatory and market price adjustment mechanisms for medicines are considerably more complex compared to standard fast-moving consumer goods.
Unprecedented Hike Breaks Historical Trends
Industry representatives noted that seasonal price increases during festival periods typically ranged between Rs 1 and Rs 3 per kg. However, the current leap—from approximately Rs 42 per kg in June to nearly Rs 65 per kg—marks an unprecedented shift. Reduced market availability alongside ongoing price fluctuations has made it increasingly complex for units to forecast baseline production expenses.
Manufacturers point out that the industrial cluster was already grappling with price hikes in plastic packaging, Active Pharmaceutical Ingredients (APIs), and LPG. The unexpected jump in sugar costs adds severe financial pressure to operating budgets.
Industry Calls for Immediate Government Intervention
With many Ayurvedic syrups and formulations relying heavily on sugar, existing inventories are running low. Industry leaders warn that if market volatility persists, overall manufacturing costs will escalate further, ultimately affecting common consumers, middle-class households, and healthcare end-users. Industry bodies are urging the government to implement effective price control measures to curb sudden surges and restore stability to the market.
